[Kashmir Reader]Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine – Kashmir Reader
New Delhi: Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The ...